These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 35884991)

  • 1. Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities.
    Stabrauskiene J; Kopustinskiene DM; Lazauskas R; Bernatoniene J
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent.
    Rauf A; Shariati MA; Imran M; Bashir K; Khan SA; Mitra S; Emran TB; Badalova K; Uddin MS; Mubarak MS; Aljohani ASM; Alhumaydhi FA; Derkho M; Korpayev S; Zengin G
    Environ Sci Pollut Res Int; 2022 May; 29(21):31025-31041. PubMed ID: 35119637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics.
    Elsori D; Pandey P; Ramniwas S; Kumar R; Lakhanpal S; Rab SO; Siddiqui S; Singh A; Saeed M; Khan F
    Front Pharmacol; 2024; 15():1406619. PubMed ID: 38957397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint.
    Emran TB; Islam F; Nath N; Sutradhar H; Das R; Mitra S; Alshahrani MM; Alhasaniah AH; Sharma R
    Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36676048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
    Yang Y; Trevethan M; Wang S; Zhao L
    J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective roles of citrus flavonoids, naringenin, and naringin on endothelial cell dysfunction in diseases.
    Adetunji JA; Fasae KD; Awe AI; Paimo OK; Adegoke AM; Akintunde JK; Sekhoacha MP
    Heliyon; 2023 Jun; 9(6):e17166. PubMed ID: 37484296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies.
    Ghanbari-Movahed M; Jackson G; Farzaei MH; Bishayee A
    Front Pharmacol; 2021; 12():639840. PubMed ID: 33854437
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical changes and antioxidant capacity of naringin and naringenin against malathion toxicity in Saccharomyces cerevisiae.
    Gerçek E; Zengin H; Erdem Erişir F; Yılmaz Ö
    Comp Biochem Physiol C Toxicol Pharmacol; 2021 Mar; 241():108969. PubMed ID: 33412300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A narrative review on Naringin and Naringenin as a possible bioenhancer in various drug-delivery formulations.
    Ganesh P; Suresh V; Narasimhan MK; Sabarathinam S
    Ther Deliv; 2023 Dec; 14(12):763-774. PubMed ID: 38088094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits.
    Hsiu SL; Huang TY; Hou YC; Chin DH; Chao PD
    Life Sci; 2002 Feb; 70(13):1481-9. PubMed ID: 11895099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringin and Naringenin: Potential Multi-Target Agents for Alzheimer's Disease.
    Lu J; Chen J; Li SY; Pan GJ; Ou Y; Yuan LF; Jiang JP; Zeng LH; Zhao J
    Curr Med Sci; 2024 Oct; 44(5):867-882. PubMed ID: 39347923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review.
    Memariani Z; Abbas SQ; Ul Hassan SS; Ahmadi A; Chabra A
    Pharmacol Res; 2021 Sep; 171():105264. PubMed ID: 33166734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytochemical Properties, Extraction, and Pharmacological Benefits of Naringin: A Review.
    Shilpa VS; Shams R; Dash KK; Pandey VK; Dar AH; Ayaz Mukarram S; Harsányi E; Kovács B
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Updated Review Summarizing the Anticancer Potential of Naringenin.
    Sharma S; Mishra A; Ramniwas S; Pandey P
    Endocr Metab Immune Disord Drug Targets; 2024 Jul; ():. PubMed ID: 39005120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
    Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
    Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
    So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
    Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of naringin in humans: a key to grapefruit juice-drug interactions?
    Fuhr U; Kummert AL
    Clin Pharmacol Ther; 1995 Oct; 58(4):365-73. PubMed ID: 7586927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of Hydrophobic and Low-Soluble Polyphenols into Nanoliposomes by pH-Driven Method: Naringenin and Naringin as Model Compounds.
    Chen M; Li R; Gao Y; Zheng Y; Liao L; Cao Y; Li J; Zhou W
    Foods; 2021 Apr; 10(5):. PubMed ID: 33924950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Metabolism of Naringin and Active Metabolite Naringenin in Rats, Dogs, Humans, and the Differences Between Species.
    Bai Y; Peng W; Yang C; Zou W; Liu M; Wu H; Fan L; Li P; Zeng X; Su W
    Front Pharmacol; 2020; 11():364. PubMed ID: 32292344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
    Massaro L; Raguzzini A; Aiello P; Valencia DV
    Endocr Metab Immune Disord Drug Targets; 2023; 23(4):428-445. PubMed ID: 36043734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.